Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection

To fight tuberculosis, better vaccination strategies are needed. Live attenuated Mycobacterium tuberculosis-derived vaccine, MTBVAC, is a promising candidate in the pipeline, proven to be safe and immunogenic in humans so far. Independent studies have shown that pulmonary mucosal delivery of Bacillu...

Descripción completa

Detalles Bibliográficos
Autores principales: Dijkman, Karin, Aguilo, Nacho, Boot, Charelle, Hofman, Sam O., Sombroek, Claudia C., Vervenne, Richard A.W., Kocken, Clemens H.M., Marinova, Dessislava, Thole, Jelle, Rodríguez, Esteban, Vierboom, Michel P.M., Haanstra, Krista G., Puentes, Eugenia, Martin, Carlos, Verreck, Frank A.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817873/
https://www.ncbi.nlm.nih.gov/pubmed/33521701
http://dx.doi.org/10.1016/j.xcrm.2020.100187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817873/
https://www.ncbi.nlm.nih.gov/pubmed/33521701
http://dx.doi.org/10.1016/j.xcrm.2020.100187

Ejemplares similares